Well-defined degradable cationic polylactide as nanocarrier for the delivery of siRNA to silence angiogenesis in prostate cancer

Adv Healthc Mater. 2012 Nov;1(6):751-61. doi: 10.1002/adhm.201200094. Epub 2012 Jul 26.

Abstract

Well-defined tertiary amine-functionalized cationic polylactides (CPLAs) are synthesized by thiol-ene click functionalization of an allyl-functionalized polylactide, and utilized for the delivery of interleukin-8 (IL-8) siRNA via CPLA-IL-8 siRNA nanoplexes. The CPLAs possess remarkable hydrolytic degradability, and their cytotoxicity is relatively low. The CPLA-IL-8 siRNA nanoplexes can be readily taken up by prostate cancer cells, resulting in significant IL-8 gene silencing. It is found that the degradability and cytotoxicity of CPLAs, as well as the transfection efficiency of the CPLA-IL-8 siRNA nanoplexes, positively correlate with the amine mol% of CPLAs.

MeSH terms

  • Absorbable Implants
  • Cell Line, Tumor
  • Gene Silencing
  • Humans
  • Male
  • Nanocapsules / chemistry*
  • Neovascularization, Pathologic / genetics
  • Neovascularization, Pathologic / therapy*
  • Polyamines / chemistry
  • Polyelectrolytes
  • Polyesters / chemistry*
  • Prostatic Neoplasms / blood supply*
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / therapy*
  • RNA, Small Interfering / administration & dosage*
  • RNA, Small Interfering / genetics

Substances

  • Nanocapsules
  • Polyamines
  • Polyelectrolytes
  • Polyesters
  • RNA, Small Interfering
  • polycations
  • poly(lactide)